These include the importance of rare mutations, the involvement of both coding as well as noncoding variation, the finding that a highly diverse array of molecules can all lead to an ASD phenotype, often coincident with intellectual disability, and the illumination of implicated biological functions, including RNA binding, synaptic structure and function, the mammalian target of the rapamycin (mTOR) pathway, and gene regulation, epigenetics, and chromatin modification [21]. The gene discussed is MTOR; the disease is Intellectual disability.